March 25, 2026 11:35 am (IST)
Emerging markets affect Dr Reddy's Laboratories' December quarter performance
Hyderabad, Feb 9 (IBNS) Dr Reddy's Laboratories Ltd announced its consolidated financial results on Tuesday for the quarter ended December 31, 2015, where it posted consolidated revenue of ₹39.7 billion, up 3 per cent from the same period in 2014, largely because the healthy performance in North America Generics (NAG), Europe and India were partially offset by emerging markets, which were impacted by unfavorable macro-economic conditions.
Revenues from the Global Generics segment for the reported quarter was ₹33.6 billion, up 7 per cent from the year-ago quarter, primarily driven by North America, Europe and India.
Revenues from the Pharmaceutical Services and Active Ingredients (PSAI) segment was ₹5.1 billion in the reported quarter, and declined by 17 per cent from the same quarter a year ago.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Sensex surges 1,200 pts, Nifty tops 23,300 as markets rally; experts warn of volatility
Wed, Mar 25 2026
Epic Games axes 1,000 employees — Is Fortnite losing its magic?
Wed, Mar 25 2026
What to Do When Home Loan Interest Rates Go Up
Tue, Mar 24 2026
Bharat Petroleum assures uninterrupted fuel, LPG supply across Bengal; urges public to avoid panic buying
Tue, Mar 24 2026
BHIM payments app introduces biometric authentication for UPI payments on Android, iOS
Tue, Mar 24 2026
India’s exports jump by $36 billion — Govt unveils big plan to dominate global trade
Tue, Mar 24 2026
Temasek-backed Manipal Health Enterprises Limited files DRHP for IPO. Check out all details
Tue, Mar 24 2026
